In-vivo CRO Market Size, Share and Growth Forecast 2025-2033
Rohit Pujari
Market Overview:
The In-Vivo CRO Market is experiencing steady expansion, driven by Increased Outsourcing by Pharmaceutical Companies, Rise of Specialized CRO Services and Growing Focus on Drug Development. According to IMARC Group's latest research publication, "In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2033",The global in-vivo CRO market size reached USD 5.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.76% during 2025-2033.
This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.
Download a sample PDF of this report: https://www.imarcgroup.com/in-vivo-cro-market/requestsample
Our Report Includes:
- Market Dynamics
- Market Trends and Outlook
- Competitive Analysis
- Industry Segmentation
- Strategic Recommendations
Growth Factors in the In-Vivo CRO Market Industry:
- Increased Outsourcing by Pharmaceutical Companies
The pharmaceutical companies are also looking towards outsourcing agencies to in-vivo contract research organization to increase the efficiency of the research and to lower the cost. Such CROs will offer targeted expertise in animal studies therefore facilitating the accelerated drug development and approval process by the regulatory agencies as well as enabling the companies concentrate on their core competencies. By way of illustration, IntegriChain, a provider of pharma complete data, consulting, technology, and outsourcing platform to commercialize data-driven, in July 2024, through the acquisition of Federal Compliance Solutions (FCS), a top pharma advisory and managed services company, to create more lucrative drug commercialization plans. This is playing the role of a growth-inducing factor as stated in the in-vivo CRO market analysis report.
- Rise of Specialized CRO Services
The emergence of niche in-vivo CRO services denotes the increased need of specialization in preclinical research. These CROs provide bespoke services in circles such as animal modeling, pharmacokinetics, and toxicology, which are more efficient and precise in therapeutic research and development and boost the in-vivo CRO market demand. An example is the all-in-one medical device CRO service that was introduced by Lindus Health in June 2024, and which integrated in-vivo CRO experience, with the latest technology and recruitment initiatives that streamline the medical device clinical trials, accelerate the recruitment of participants across different therapeutic areas and regulatory pathways, etc.
- Growing Focus on Drug Development
The rising interest in drug development has given rise to increased support of the in-vivo CRO. Such organizations offer the most critical services in preclinical testing, which helps the pharmaceutical companies determine the safety and effectiveness of novel drugs in living organisms and quickens the development cycle and minimizes expenses and resource utilization. Indicatively, in May 2024, Cannovation Clinical Research Partners became a CRO that conducts cannabis based drug trials, concentrating on preclinical and clinical trials, and developed cannabinoid based therapeutics with pharmaceutical companies, universities, and researchers at the DEA.
Key Trends in the In-Vivo CRO Market:
- Growing Prevalence of Chronic Diseases
The market is being driven by the rising prevalence of chronic diseases in the world and the rise in the amount of money spent by pharmaceutical companies in research and development. The in-vivo CRO market environment is changing dramatically due to consumer knowledge regarding health and wellness. The citizens are becoming more aware of disease prevention and finding real solutions to treatment. The contemporary customer does a thorough research on products before resolving on healthcare. The governments and organizations have conducted health awareness campaigns which have sensitized masses about the importance of preventive care. Health experts and social media influencers also take the habit of promoting wellness products to their followers. Increasing lifestyle diseases have led to people being active concerning their health management plans. The younger generations especially are keen on ensuring good health using advanced medical care. Online availability of health information has democratized the knowledge on wellness among demographics. This increasing consciousness generates sustainable needs of the in-vivo CRO market applications.
- Advanced Rodent Models and Enhanced Services
The in-vivo CRO market is new and innovates by providing new and better services. The companies invest in research and development in order to develop a better solution. The development of advanced technologies will allow improving the study design and increasing the effectiveness of research results. Organizations come up with special services that serve particular treatment specialties and research divisions. Trends in the industry drive the providers towards the novel method and open-minded approaches. The innovation in technology enhances services, and thus they become efficient and reliable to both large and small clients. Delivery of services innovations enhances quality of research, as well as user experience. Niche versions expand into the pharmaceutical and biotech clients. Scientists and CROs work together to bring innovative solutions in the market. Competitive advantage and market leadership are still based on innovation.
- Expansion of Research Infrastructure
The expanding research networks around the world are of the great advantage to the in-vivo CRO market. The contemporary research establishments enhance the visibility of services and access points to clients. The research centers of specialties offer the expert consultation and the possibility of the services. Healthcare alliances place services in reliable healthcare setting. Online services have a great variety of service choices and price competition benefits. Online cooperation renders organization of research very convenient to busy customers. The services of real time data increase the attractiveness of research. Through international alliances, top organizations can access the global market. Market entry is speedy due to distribution arrangements with established pharmaceutical firms. The use of multi-channel strategies will guarantee homogenous service experience among platforms. Improved research facilities enable continued growth of the market.
Leading Companies Operating in the Global In-Vivo CRO Market Industry:
- Biocytogen
- Charles River Laboratories
- Crown Bioscience
- Eurofins Discovery
- Evotec
- Fortrea
- Icon Plc
- IQVIA Inc.
- Iris Pharma
- Taconic Biosciences, Inc.
- WuXi AppTec
In-Vivo CRO Market Report Segmentation:
Breakup by Type:
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
Rodent exhibited a clear dominance in the market due to favorable market conditions and strong consumer demand.
Breakup by GLP Type:
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
GLP Toxicology exhibited a clear dominance in the market due to favorable market conditions and strong consumer demand.
Breakup by Indication:
- Autoimmune/Inflammation Conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable Bowel Syndrome
- Others
- Pain Management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Others
- CNS Conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle Regeneration
- Others
- Diabetes
- Obesity
- Others
Oncology exhibited a clear dominance in the market due to favorable market conditions and strong consumer demand.
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America dominated the global market due to abundant resources, favorable government initiatives, and well-established infrastructure.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sa...@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302